⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PSTV News
PLUS THERAPEUTICS, Inc. Common Stock
Cerenome Launches as an Integrated CNS Oncology Company
globenewswire.com
PSTV
Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference
globenewswire.com
PSTV
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
globenewswire.com
PSTV
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
globenewswire.com
PSTV
Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring
globenewswire.com
PSTV
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
globenewswire.com
PSTV
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
globenewswire.com
PSTV
ELV
Plus Therapeutics to Provide Business Update Call on June 30, 2026
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
globenewswire.com
PSTV